BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//6.0.1.1//EN
BEGIN:VEVENT
UID:b63bd1b5-0b2f-40da-b5fc-93a651179bbb
DTSTART:20260818T070000Z
DTEND:20260820T170000Z
DTSTAMP:20260421T080040Z
SUMMARY:6th Rare and Genetic Kidney Disease DD Summit
DESCRIPTION:The 6th Rare and Genetic Kidney Disease Drug Development Summit is the industry's only meeting dedicated exclusively to advancing therapies across IgAN\, FSGS\, ADPKD\, Alport syndrome\, C3G\, and related renal indications. Bringing together leaders from biopharma\, academia\, and patient advocacy\, this summit spans discovery through commercialization to support smarter\, faster decision-making across kidney disease pipelines.\n\nAs competition intensifies in rare and genetic kidney disease drug development\, companies are under increasing pressure to differentiate assets\, generate robust clinical evidence\, and accelerate timelines to patients. Accelerated approval pathways have fundamentally reshaped how teams approach target evaluation\, surrogate endpoint selection\, and trial design within small\, heterogeneous patient populations. With more programs progressing into mid- and late-stage development than ever before\, the stakes for getting these decisions right have never been higher.
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massachusetts\, 02116\, United States
URL:https://eventstopten.com/events/6th-rare-and-genetic-kidney-disease-dd-summit/
END:VEVENT
END:VCALENDAR